Vitamin K2 Market Research Report—Global Forecast till 2027

ビタミンK2市場:製品タイプ別(MK-7、MK-4および併用薬)、供給源(天然および合成)、形態別(カプセルおよび錠剤、粉末、油)、用途別(栄養補助食品および食品および医薬品)および地域別(南北アメリカ、ヨーロッパ、アジア太平洋、中東およびアフリカ)—2027年までの予測

ID: MRFR/HC/6026-CR | November 2021 | Region: Global | 117 Pages         

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PATIENT POOL SUFFERING FROM VITAMIN DEFICIENCY

4.2.2 GROWING DEMAND FOR NUTRACEUTICAL PRODUCTS CONTAINING VITAMIN K2

4.2.3 RISING CASES OF OSTEOPOROSIS AND ARTHRITIS

4.3 RESTRAINTS

4.3.1 STRINGENT REGULATIONS FOR NUTRACEUTICALS

4.4 OPPORTUNITY

4.4.1 MULTIFUNCTIONAL INGREDIENTS

5 MARKET FACTOR ANALYSIS

5.1 PORTER'S FIVE FORCES MODEL

5.1.1 THREAT OF NEW ENTRANTS

5.1.2 BARGAINING POWER OF SUPPLIERS

5.1.3 THREAT OF SUBSTITUTES

5.1.4 BARGAINING POWER OF BUYERS

5.1.5 RIVALRY

5.2 SUPPLY CHAIN ANALYSIS

5.2.1 RAW MATERIAL PLANNING & PROCUREMENT

5.2.1.1 FERMENTATION

5.2.1.2 FILTRATION

5.2.1.3 EXTRACTION

5.2.1.4 FILTRATION PURIFICATION

5.2.2 PACKAGING

5.2.3 TRANSPORTATION

5.2.4 DISTRIBUTION MARKETING & SALES

5.2.5 POST-SALES SERVICES

5.3 COVID-19 IMPACT ANALYSIS

5.3.1 IMPACT ON R&D

5.3.2 IMPACT ON SUPPLY CHAIN

5.3.3 IMPACT ON RAW MATERIAL

5.3.4 IMPACT ON DEMAND

6 GLOBAL VITAMIN K2 MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 MK-7

6.3 MK-4

6.4 COMBINATION DRUGS

7 GLOBAL VITAMIN K2 MARKET, BY SOURCE

7.1 OVERVIEW

7.2 NATURAL

7.3 SYNTHETIC

8 GLOBAL VITAMIN K2 MARKET, BY FORM

8.1 OVERVIEW

8.2 CAPSULE & TABLETS

8.3 POWDER

8.4 OILS

8.5 OTHERS

9 GLOBAL VITAMIN K2 MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 NUTRACEUTICAL AND FOOD

9.3 PHARMACEUTICAL

10 GLOBAL VITAMIN K2 MARKET, BY REGION

10.1 OVERVIEW

10.2 AMERICAS

10.2.1 NORTH AMERICA

10.2.1.1 US

10.2.1.2 CANADA

10.2.2 SOUTH AMERICA

10.3 EUROPE

10.3.1 WESTERN EUROPE

10.3.1.1 GERMANY

10.3.1.2 FRANCE

10.3.1.3 UK

10.3.1.4 ITALY

10.3.1.5 SPAIN

10.3.1.6 REST OF WESTERN EUROPE

10.3.2 EASTERN EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 JAPAN

10.4.3 INDIA

10.4.4 AUSTRALIA

10.4.5 SOUTH KOREA

10.4.6 REST OF ASIA-PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST

10.5.2 AFRICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 COMPETITIVE BENCHMARKING

11.3 MAJOR GROWTH STRATEGY IN THE VITAMIN K2 MARKET

11.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE VITAMIN K2 MARKET

11.5 KEY DEVELOPMENT ANALYSIS

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL

11.6.2 PARTNERSHIP/ ACQUISITION

11.6.3 PRODUCT PROMOTION/EXPANSION

11.7 FINANCIAL MATRIX

11.7.1 SALES, 2020

11.7.2 R&D EXPENDITURE

12 COMPANY PROFILES

12.1 KAPPA INGREDIENTS GMBH

12.1.1 COMPANY OVERVIEWS

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS/SERVICES OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 LESAFFRE & CIE

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

This is a privately held company. Hence, the financial information is not available in the public domain.

12.2.3 PRODUCTS/SERVICES OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 VIRIDIS BIOPHARMA PVT. LTD.

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 SEEBIO BIOTECH (SHANGHAI) CO., LTD.

12.4.1 COMPANY OVERVIEWS

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS/SERVICES OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 DSM

12.5.1 COMPANY OVERVIEWS

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS/SERVICES OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 INTERNATIONAL FLAVORS & FRAGRANCES INC.

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS/SERVICES OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 SWOT ANALYSIS

12.6.6 KEY STRATEGIES

12.7 KYOWA HAKKO BIO CO. LTD.

12.7.1 COMPANY OVERVIEWS

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS/SERVICES OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 PURAYATI

12.8.1 COMPANY OVERVIEWS

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS/SERVICES OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 VOX NUTRITION INC.

12.9.1 COMPANY OVERVIEWS

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS/SERVICES OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 SWOT ANALYSIS

12.9.6 KEY STRATEGIES

12.10 ANDERSON GLOBAL GROUP, LLC

12.10.1 COMPANY OVERVIEWS

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS/SERVICES OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 SWOT ANALYSIS

12.10.6 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS


LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018-2027 (USD MILLION)

TABLE 4 GLOBAL VITAMIN K2 MARKET FOR MK-7, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 GLOBAL VITAMIN K2 MARKET FOR MK-4, BY REGION, 2018-2027 (USD MILLION)

TABLE 6 GLOBAL VITAMIN K2 MARKET FOR COMBINATION DRUGS, BY REGION, 2018-2027 (USD MILLION)

TABLE 7 GLOBAL VITAMIN K2 MARKET, BY SOURCE, 2018-2027 (USD MILLION)

TABLE 8 GLOBAL VITAMIN K2 MARKET, FOR NATURAL, BY REGION 2018-2027 (USD MILLION)

TABLE 9 GLOBAL VITAMIN K2 MARKET, FOR SYNTHETIC, BY REGION 2018-2027 (USD MILLION)

TABLE 10 GLOBAL VITAMIN K2 MARKET, BY FORM, 2018-2027, (USD MILLION)

TABLE 11 GLOBAL VITAMIN K2 MARKET FOR CAPSULE & TABLETS, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 GLOBAL VITAMIN K2 MARKET FOR POWDER, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 GLOBAL VITAMIN K2 MARKET FOR OILS, BY REGION, 2018-2027 (USD MILLION)

TABLE 14 GLOBAL VITAMIN K2 MARKET FOR OTHERS, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 GLOBAL VITAMIN K2 MARKET, BY APPLICATION, 2018-2027 (USD MILLION)

TABLE 16 GLOBAL VITAMIN K2 MARKET FOR NUTRACEUTICAL AND FOOD, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 GLOBAL VITAMIN K2 MARKET FOR PHARMACEUTICAL, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 GLOBAL: VITAMIN K2 MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 19 AMERICAS: VITAMIN K2 MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 20 AMERICAS: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 21 AMERICAS: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 22 AMERICAS: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 23 AMERICAS: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 24 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 25 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 26 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 27 NORTH AMERICA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 28 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 29 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 30 US: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 31 US: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 32 US: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 33 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 34 CANADA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 35 CANADA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 36 CANADA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 37 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 38 SOUTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 39 SOUTH AMERICA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 40 SOUTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 41 EUROPE: VITAMIN K2 MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 42 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 43 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 44 EUROPE: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 45 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 46 WESTERN EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 47 WESTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 48 WESTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 49 WESTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 50 WESTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 51 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 52 GERMANY: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 53 GERMANY: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 54 GERMANY: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 55 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 56 FRANCE: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 57 FRANCE: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 58 FRANCE: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 59 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 60 UK: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 61 UK: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 62 UK: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 63 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 64 ITALY: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 65 ITALY: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 66 ITALY: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 67 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 68 SPAIN: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 69 SPAIN: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 70 SPAIN: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 71 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 72 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 73 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 74 REST OF WESTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 75 EASTERN EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 76 EASTERN EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 77 EASTERN EUROPE: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 78 EASTERN EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 79 ASIA-PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 80 ASIA-PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 81 ASIA-PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 82 ASIA-PACIFIC: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 83 ASIA-PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 84 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 85 CHINA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 86 CHINA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 87 CHINA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 88 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 89 JAPAN: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 90 JAPAN: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 91 JAPAN: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 92 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 93 INDIA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 94 INDIA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 95 INDIA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 96 AUSTRALIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 97 AUSTRALIA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 98 AUSTRALIA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 99 AUSTRALIA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 100 SOUTH KOREA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 101 SOUTH KOREA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 102 SOUTH KOREA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 103 SOUTH KOREA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 104 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 105 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 106 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 107 REST OF ASIA-PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 108 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 109 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 110 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 111 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 112 MIDDLE EAST & AFRICA: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 113 MIDDLE EAST: PROTEIN ENGINEERING MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 114 MIDDLE EAST: PROTEIN ENGINEERING MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 115 MIDDLE EAST: PROTEIN ENGINEERING MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 116 MIDDLE EAST: PROTEIN ENGINEERING MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 117 AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2018–2027 (USD MILLION)

TABLE 118 AFRICA: VITAMIN K2 MARKET, BY SOURCE, 2018–2027 (USD MILLION)

TABLE 119 AFRICA: VITAMIN K2 MARKET, BY FORM, 2018–2027 (USD MILLION)

TABLE 120 AFRICA: VITAMIN K2 MARKET, BY APPLICATION, 2018–2027 (USD MILLION)

TABLE 121 MAJOR MANUFACTURERS IN THE VITAMIN K2 MARKET

TABLE 122 MOST ACTIVE PLAYER IN THE VITAMIN K2 MARKET

TABLE 123 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 124 PARTNERSHIP/ ACQUISITION

TABLE 125 PRODUCT PROMOTION/EXPANSION

TABLE 126 KAPPA INGREDIENTS GMBH: PRODUCTS/SERVICES OFFERED

TABLE 127 KAPPA INGREDIENTS GMBH: KEY DEVELOPMENTS

TABLE 128 LESAFFRE: PRODUCTS/SERVICES OFFERED

TABLE 129 LESAFFRE: KEY DEVELOPMENTS

TABLE 130 VIRIDIS BIOPHARMA PVT. LTD. : PRODUCTS/SERVICES OFFERED

TABLE 131 SEEBIO BIOTECH (SHANGHAI) CO., LTD: PRODUCTS/SERVICES OFFERED

TABLE 132 DSM: PRODUCTS/SERVICES OFFERED

TABLE 133 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SERVICES OFFERED

TABLE 134 INTERNATIONAL FLAVORS & FRAGRANCES INC.: KEY DEVELOPMENTS

TABLE 135 KYOWA HAKKO BIO CO.: PRODUCTS/SERVICES OFFERED

TABLE 136 PURAYATI.: PRODUCTS/SERVICES OFFERED

TABLE 137 VOX NUTRITION INC.: PRODUCTS/SERVICES OFFERED

TABLE 138 ANDERSON GLOBAL GROUP, LLC.: PRODUCTS/SERVICES OFFERED


LIST OF FIGURES

FIGURE 1 GLOBAL CELL CULTURE MEDIA MARKET STRUCTURE

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CELL CULTURE MEDIA MARKET

FIGURE 4 SUPPLY CHAIN ANALYSIS: GLOBAL CELL CULTURE MEDIA MARKET

FIGURE 5 PORTER’S FIVE FORCES MODEL

FIGURE 6 GLOBAL CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2019 & 2027 (USD MILLION)

FIGURE 7 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019 & 2027 (USD MILLION)

FIGURE 8 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER, 2019 & 2027 (USD MILLION)

FIGURE 9 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)

FIGURE 10 AMERICAS: CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)

FIGURE 11 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019 & 2027 (USD MILLION)

FIGURE 12 EUROPE: CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)

FIGURE 13 WESTERN EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019 & 2027 (USD MILLION)

FIGURE 14 ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019 & 2027 (USD MILLION)

FIGURE 15 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)

FIGURE 16 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 17 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CELL CULTURE MEDIA MARKET

FIGURE 18 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 19 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS

FIGURE 20 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 MERCK KGAA: SWOT ANALYSIS

FIGURE 22 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS

FIGURE 24 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 GE HEALTHCARE: SWOT ANALYSIS

FIGURE 26 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS

FIGURE 28 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 29 DANAHER CORPORATION: SWOT ANALYSIS

FIGURE 30 BIOMÉRIEUX SA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 31 BIOMÉRIEUX SA: SWOT ANALYSIS

FIGURE 32 LONZA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 LONZA: SWOT ANALYSIS

FIGURE 34 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW

FIGURE 35 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS

FIGURE 36 HIMEDIA LABORATORIES: SWOT ANALYSIS

FIGURE 37 CORNING INCORPORATED: FINANCIAL OVERVIEW

FIGURE 38 ORNING INCORPORATED: SWOT ANALYSIS

FIGURE 39 PROMOCELL: SWOT ANALYSIS

FIGURE 40 THE SARTORIUS GROUP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 41 THE SARTORIUS GROUP: SWOT ANALYSIS

FIGURE 42 FUJIFILM HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 43 FUJIFILM HOLDINGS CORPORATION: SWOT ANALYSIS

ビタミンK2マーケット

ビタミンK2市場は、2027年までに31.08%のCAGRで7億382百万米ドルを超えると予想されています。

セグメンテーション

製品タイプ別 Mk 7 Mk 4 And Combination Drugs
By Source Natural And Synthetic
By Form Capsules & Tablets Powder Oil
アプリケーション別 Nutraceutical & Food And Pharmaceutical

キープレーヤー

  • Kappa Bioscience (Norway)
  • Lesaffre (France)
  • Viridis BioPharma (India)
  • Seebio Biotech (Shanghai) Co.
  • Ltd (China)
  • DSM (Netherlands)

運転手

  • Increasing patient pool suffering from vitamin deficiency
  • Growing demand for nutraceutical products containing vitamin K2
Speak to Analyst Request a Free Sample

ビタミンK2市場予測


ビタミンK2市場は、2027年までに31.08%のCAGRで7億382百万米ドルを超えると予想されています。


市場の概要:


生活習慣や食生活の変化により、ビタミンK2欠乏症の症例が増えています。ビタミンK2は、人間の腸内でバクテリアによって自然に生成されます。ビタミンK2は西洋の食事ではまれであり、補助的な食事や医薬品を通じてビタミンK2を関与させる必要があります。市場の成長に起因する主な要因には、ビタミン欠乏症に苦しむ患者プールの増加、ビタミンK2を含む栄養補助食品の需要の増加、および骨粗しょう症と関節炎の症例の増加が含まれます。ただし、栄養補助食品に関する厳しい規制は、予測期間中の市場の成長を妨げる可能性があります。それどころか、多機能成分は、市場のプレーヤーが高度な製品を開発する機会を提供します。


COVID-19分析:


COVID-19の蔓延率の上昇は、予測期間中の市場の成長に影響を与えると予測されています。COVID-19の危機は、ヘルスケア部門に直接的かつ大きな影響を与えました。コロナウイルスの発生の初期段階では、ほとんどの製薬会社および栄養補助食品会社は、サプライチェーンへの突然の影響と製造および供給業務に対する制限により、最初の数四半期にわずかな損失を経験しました。しかし、COVID-19はビタミンK2を含む栄養補助食品の需要の増加につながり、いくつかの主要なプレーヤーは需要の増加により売上高のプラスの成長を目の当たりにしています。


市場動態:


マーケットドライバー


  • ビタミン欠乏症に苦しむ患者プールの増加


近年、ビタミン欠乏症の症例数は絶えず増加しています。増加するビタミン欠乏症は、ビタミンを含む栄養補助食品の需要の増加の原因となっています。さらに、ビタミンK欠乏出血(VKDB)は、血栓を形成するのに十分なビタミンKが血液に含まれていないため、赤ちゃんが出血を止めることができない状態です。疾病管理予防センター(CDC)によると、医療提供者はVKDBを早期、古典的、後期の3つのタイプに分類します。早期および古典的VKDBはより一般的であり、新生児の60人に1人から250人に1人に発生し、後期VKDBはまれで、14,000人に1人から25,000人に1人に発生する。さらに、国連食糧農業機関(FAO)が発表した報告書によると、乳児のビタミンK欠乏出血(VKDB)は深刻な懸念事項であり、タイにおけるVKDBの有病率は出生10万人あたり72です。



  • ビタミンK2を含む栄養補助食品の需要の高まり

  • 骨粗しょう症と関節炎の増加例


市場制約


  • 栄養補助食品に関する厳しい規制


栄養補助食品市場の主要なプレーヤーは、政府が設定した基準を満たすために、政府によって設定された規則と規制を満たす必要があります。関係当局は、許可の管理、新規プレイヤーの参入に関する規制の設定、残余管理の問題、および栄養補助食品などの特定の製品の有効期限の検査に責任があります。FDAは、米国における機能性食品と栄養補助食品の製造と流通を規制する責任があります。


市場機会


  • 多機能成分


近年、市場の技術的進歩により、多機能栄養成分の開発が進み、相乗的にさまざまな複雑な栄養補助食品および医薬品製剤の機能的性能の向上につながっています。さらに、そのような成分は、バインダー、潤滑剤、滑走剤などの必要性を減少させると推定されています。したがって、これらの成分の多機能性は、他の技術と比較して製造コストの大幅な節約につながります。


世界のビタミンK2市場シェア (%)、製品タイプ別、2020年
Vitamin K2 Market Share by Product Type 2020
ソース:MRFR 分析


セグメント概要


世界のビタミンK2市場は、製品の種類、供給源、形態、用途に基づいて分割されています。


製品タイプ別



  • MK-7


ビタミンK2 MK-7(メナキノン-7)は、大豆の細菌発酵に由来し、製造施設で作成および処理されます。栄養補助食品に使用されています。MK-7は、納豆に天然に存在するビタミンK2の強化された生理活性型であり、骨を作るのに必要な特定の骨タンパク質のカルボキシル化に関与しています。



  • MK-4


ビタミンK2 MK-4(メナキノン-4)は、骨の健康を促進し、血液凝固とプロトロンビンの形成をサポートする合成MK-4としてサプリメントや機能性食品に含まれています。MK-4は、卵、バター、チーズ、動物製品に含まれるK2の短鎖形態です。これは、MK-7と比較して半減期が短い合成ビタミンK2化合物です。骨量減少を止めて逆転させ、強い骨につながり、骨折の可能性を減らします。



  • 併用薬


併用薬セグメントには、MK7+MK4、K2+D3、MK4からMK7プラスMK8/9/10、D3+MK7+MK4などの併用薬が含まれていました。ビタミンD3とビタミンK2を組み合わせると、カルシウムが吸収されやすくなり、動脈の石灰化を防ぎながら骨量に到達します。


ソース別


供給源に基づいて、世界のビタミンK2市場は天然と合成に分かれています。



  • ナチュラル


天然ビタミンKは濃い葉野菜に含まれており、正常な血液凝固と代謝経路に不可欠です。ビタミンK2が豊富な食品には、発酵大豆、納豆、ガチョウの肝臓、チーズ、卵黄、ダークチキンの肉/サラミ、ザワークラウト、バターが含まれます。天然ビタミンK2は、止血、抗骨粗しょう症、および抗酸化特性を持つ脂溶性化合物のグループであるビタミンKファミリーの一部です。



  • 合成


合成ビタミンK2は、ゲラニオールとファルネソールの花抽出物に由来し、天然大豆ベースのMK-7の代替品です。2010年8月、ノルウェーの原料サプライヤーであるKappa Bioscience ASは、市販されている既存の形態と同様のバイオアベイラビリティーを持ち、ビタミンK2の天然成分(大豆ベースの成分)よりも低価格で入手可能なビタミンK2の合成形態を開発しました。


フォーム別


形態に基づいて、市場はカプセルと錠剤、粉末、油、および錠剤、カプセル、ソフトジェルなどの他のものに分けられます。。



  • カプセル&タブレット


ビタミンK2製品は、カプセル、錠剤、またはソフトジェルの形で広く消費されています。いくつかの主要企業は、高い嗜好性と入手しやすいことから、カプセルおよび錠剤の形でビタミンK2サプリメントを製造しています。主要企業は、製品ポートフォリオを強化するために、カプセル化に関わる技術の向上に重点を置いています。ビタミンK2市場では、これらの形態に利用可能な幅広い製品ポートフォリオがあります。



  • パウダー


粉末状のビタミンK2製品は、水と一緒に摂取すると、カプセルや錠剤よりも体内でより迅速かつ効率的に吸収されます。Gnosis SPA(イタリア)は、VitamK7パウダーを乾燥した天然バイオマスとして、またはマルトデキストリンとブレンドしたバルクとして提供しています。



  • オイル


<スパンスタイル= "f



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 703.82 Million
  CAGR   31.08%
  Base Year   2020
  Forecast Period   2021-2027
  Historical Data   2018 & 2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Source, Form, Application and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   • Kappa Bioscience (Norway) • Lesaffre (France) • Viridis BioPharma (India) • Seebio Biotech (Shanghai) Co.,Ltd (China) • DSM (Netherlands) • International Flavors & Fragrances Inc. (US) • Kyowa Hakko Bio Co. Ltd (Japan) • Purayati (India) • Vox Nutrition (US) • Anderson Global Group, LLC. (US)
  Key Market Opportunities   • Stringent regulations for nutracueticals
  Key Market Drivers   • Increasing patient pool suffering from vitamin deficiency • Growing demand for nutraceutical products containing vitamin K2 • Rising cases of osteoporosis and arthritis


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Vitamin K2 market is projected to grow at a 31.08% CAGR between 2021-2027.

Vitamin K2 market is predicted to touch USD 329.63 million by 2025.

The Americas is expected to lead vitamin K2 market.

Rising cases of vitamin deficiency and increasing prevalence of osteoporosis are the key factors driving the vitamin K2 market.

Strict government regulations may limit the vitamin K2 market growth.